The largest database of trusted experimental protocols

D 2 amino 5 phosphonovalerate d ap5

Manufactured by Merck Group
Sourced in United States, United Kingdom

D-2-amino-5-phosphonovalerate (D-AP5) is a synthetic organic compound that functions as an N-methyl-D-aspartate (NMDA) receptor antagonist. It is primarily used in scientific research applications to study the role of NMDA receptors in various biological processes.

Automatically generated - may contain errors

2 protocols using d 2 amino 5 phosphonovalerate d ap5

1

Calcium Signaling Pathway Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Materials were purchased from the following companies: fura-2 acetoxymethyl ester (AM) from Molecular Probes (Eugene, OR, USA); Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) from Invitrogen (Carlsbad, CA, USA); the AMPA receptor antagonist 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo [f] quinoxaline-7-sulfonamide (NBQX), the L-type Ca2+ channel antagonist nimodipine, PKCε translocation inhibitor and PKCζ pseudosubstrate inhibitor, CaMKII inhibitor KN-62 from Calbiochem (San Diego, CA, USA); the NMDA receptor antagonist D-2-amino-5-phosphonovalerate (D-AP5), the intracellular calcium chelator BAPTA, 1,2-bis(2-aminophenoxy)ethane-*N,N,N',N'-tetraacetic acid; the nonspecific PKC inhibitor staurosporin, the JAK-2 inhibitor AG490, the MAPK kinase inhibitor PD98059 and all other reagents from Sigma (St. Louis, MO, USA). Mg2+ free-DMEM (DMEM without MgSO4) was purchased from WelGENE (Korea) as a customer-ordered item.
+ Open protocol
+ Expand
2

Isolating Retinal Light Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The glutamatergic blockers L (+)-2-amino-4-phosphonobutyrate (L-AP4) (group III metabotropic glutamate receptor agonist) (50 μM), 6, 7-dinitroquinoxaline-2, 3-dione (DNQX) (AMPA/kainate receptor antagonist) (40 μM), and d-2-amino-5-phosphonovalerate (d-AP5) (NMDA receptor antagonist; all from Sigma Aldrich, UK) (40 μM) were added to the AMES media, to block synaptic input from outer retinal photoreceptors and identify the origin of light responses in retinal explants. Under these conditions, we repeated the 1 s light pulses described above. Following this protocol, the drugs were washed out and the MEA chamber was cleared with AMES media (Sigma Aldrich, UK) for 1 hour before repeating the same 1 s light stimulation protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!